DK199783A - Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer - Google Patents

Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer Download PDF

Info

Publication number
DK199783A
DK199783A DK199783A DK199783A DK199783A DK 199783 A DK199783 A DK 199783A DK 199783 A DK199783 A DK 199783A DK 199783 A DK199783 A DK 199783A DK 199783 A DK199783 A DK 199783A
Authority
DK
Denmark
Prior art keywords
procedures
preparation
hybrid antibodies
half molecules
immunoglobulin
Prior art date
Application number
DK199783A
Other languages
English (en)
Other versions
DK199783D0 (da
Inventor
Karen Auditore-Hargreaves
Frederick Miesowicz
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/374,970 external-priority patent/US4446233A/en
Priority claimed from US06/374,971 external-priority patent/US4479895A/en
Application filed by Du Pont filed Critical Du Pont
Publication of DK199783D0 publication Critical patent/DK199783D0/da
Publication of DK199783A publication Critical patent/DK199783A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Description

kyle tilvejebringer et bindingssted for et første antigen, og det andet halvmolekyle tilvejebringer et kemisk forskelligt bindingssted for det første eller et andet antigen.
Til immunoprøvning for analyter, såsom antigener eller haptener, anvendes det ovenfor fremstillede covalente hybrid-antistof til modulering af aktiviteten af indikatorer. Hybrid-antistoffet har i dette tilfælde bindingssteder for analyten og indikatoren. Slutaktiviteten af indikatoren er proportional med analytkoncentrationen.
·>
DK199783A 1982-05-05 1983-05-04 Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer DK199783A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/374,970 US4446233A (en) 1982-05-05 1982-05-05 Homogeneous immunoassay using covalent hybrid antibodies
US06/374,971 US4479895A (en) 1982-05-05 1982-05-05 Immunoglobulin half-molecules and process for producing hybrid antibodies
US37497182 1982-05-05
US37497082 1982-05-05

Publications (2)

Publication Number Publication Date
DK199783D0 DK199783D0 (da) 1983-05-04
DK199783A true DK199783A (da) 1983-11-06

Family

ID=27006845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199783A DK199783A (da) 1982-05-05 1983-05-04 Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer

Country Status (5)

Country Link
EP (1) EP0096463B1 (da)
JP (1) JPH05295000A (da)
CA (1) CA1194415A (da)
DE (1) DE3368064D1 (da)
DK (1) DK199783A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004811A1 (en) * 1984-04-23 1985-11-07 Boston Biomedical Research Institute, Inc. Bispecific antibody determinants
NL8501219A (nl) * 1985-04-29 1986-11-17 Stichting Vrienden Van De Stic Immunologisch complex, de bereiding en toepassing daarvan.
US4954617A (en) * 1986-07-07 1990-09-04 Trustees Of Dartmouth College Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
GB8626767D0 (en) * 1986-11-10 1986-12-10 Unilever Plc Assays
US5086002A (en) * 1987-09-07 1992-02-04 Agen Biomedical, Ltd. Erythrocyte agglutination assay
OA08953A (fr) * 1987-09-17 1990-11-30 Agen Ltd Agglutination assay
IT1235349B (it) * 1988-12-23 1992-06-30 Biodata Spa Saggio immunologico per determinazioni in fase omogenea
WO1992019973A1 (en) * 1991-04-26 1992-11-12 Surface Active Limited Novel antibodies, and methods for their use
US5447846A (en) * 1992-07-17 1995-09-05 Fuji Photo Film C., Ltd. Homogeneous Immunoassay process using covalent conjugate of enzyme and plural monoclonal antibodies for different epitopes on analyte
GB9316369D0 (en) * 1993-08-06 1993-09-22 Surface Active Ltd Diagnostic method
JP2005172694A (ja) * 2003-12-12 2005-06-30 Fuji Photo Film Co Ltd タンパク質の検出方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2508132C3 (de) * 1974-03-08 1980-10-16 Teijin Ltd., Osaka (Japan) Verfahren zur Herstellung von Humanimmunglobulin-Derivaten und parenteral applizierbare Lösung hiervon
US4156081A (en) * 1977-04-15 1979-05-22 Syva Company Theophylline antigens and antibodies
DE3173342D1 (en) * 1980-03-03 1986-02-13 Milton David Goldenberg Agent for tumor localization and therapy with labeled antibodies and antibody fragments
DE3134361A1 (de) * 1981-08-31 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur enzymimmuno-bestimmung in homogener phase

Also Published As

Publication number Publication date
EP0096463A1 (en) 1983-12-21
DE3368064D1 (en) 1987-01-15
CA1194415A (en) 1985-10-01
JPH05295000A (ja) 1993-11-09
EP0096463B1 (en) 1986-12-03
DK199783D0 (da) 1983-05-04

Similar Documents

Publication Publication Date Title
US5468648A (en) Interrupted-flow assay device
PT89889A (pt) Processo para a preparacao de testes imunologicos contendo derivados de igg polimericos para a compensacao de factores perturbantes
EP0399184A3 (en) Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
ATE14630T1 (de) Creatinin-antikoerper.
KR960029789A (ko) 생체내 물질의 면역학적 분석용 키트 및 면역학적 분석 방법
DK199783A (da) Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer
DE3576854D1 (de) Immunchemisches messverfahren fuer haptene und proteine.
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
NO874140L (no) Immunometriske bestemmelsesfremgangsmaater.
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
US4816387A (en) Method for detection of antibodies to HTLV-III and diagnostic test kit useful therewith
ES2061881T3 (es) Procedimiento para la determinacion de anticuerpos especificos de la clase de un antigeno asi como un reactivo apropiado para ello.
ATE50459T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
ATE80467T1 (de) Immuntestverfahren.
ES2036189T3 (es) Un metodo para efectuar un inmunoensayo de diagnostico.
EP0250119A3 (en) Atherosclerotic anti-idiotype antibody immunoassay and reagents
KR910006728A (ko) 분석물의 검출 방법
KR850003169A (ko) 염기성 태아단백질의 측정방법 및 시약
KR930000951A (ko) 진단 방법
FR2383962A1 (fr) Determination de beta-lipotropine humaine
KR890005520A (ko) 응집반응 측정법
DE3863270D1 (de) Immuntest.
KR830004829A (ko) 매독 진단법

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment